MVR-C5252

· Duke University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVR-C5252, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252 [Phase 1]